Intercept Pharmaceuticals (ICPT) Prices IPO at $15 Per Share
Tweet
Share
E-mailGet Alerts ICPT Hot Sheet
Join SI Premium – FREE
Intercept Pharmaceuticals, Inc., (Nasdaq: ICPT) a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the common stock is being offered by Intercept.
In addition, the underwriters have a 30-day option to purchase up to an additional 750,000 shares of common stock from Intercept. The Company's shares are expected to begin trading on The NASDAQ Global Market on Thursday, October 11, 2012 under the trading symbol (Nasdaq: ICPT).
In addition, the underwriters have a 30-day option to purchase up to an additional 750,000 shares of common stock from Intercept. The Company's shares are expected to begin trading on The NASDAQ Global Market on Thursday, October 11, 2012 under the trading symbol (Nasdaq: ICPT).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scribe Therapeutics prices IPO at $15 per share on Nasdaq
- Jersey Mike's Subs files for 43.48M share IPO
- Reformation files for 14.06M share IPO on NYSE at $15-$17 per share
Create E-mail Alert Related Categories
IPOsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
